Timosaponin A-Iii Reverses Multi-Drug Resistance in Human Chronic Myelogenous Leukemia K562/Adm Cells via Downregulation of MDR1 and MRP1 Expression by Inhibiting PI3K/Akt Signaling Pathway

International Journal of Oncology - Greece
doi 10.3892/ijo.2016.3423
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

TRIB2 Knockdown as a Regulator of Chemotherapy Resistance and Proliferation via the ERK/STAT3 Signaling Pathway in Human Chronic Myelogenous Leukemia K562/Adm Cells

Oncology Reports
MedicineCancer ResearchOncology
2018English

Downregulation of NEAT1 Reverses the Radioactive Iodine Resistance of Papillary Thyroid Carcinoma Cell via miR-101-3p/FN1/PI3K-AKT Signaling Pathway

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2018English

Diosgenin Inhibits Cell Proliferation of Primary Human Thyrocytes via Downregulation of PI3K/Akt Signaling Pathway

Tropical Journal of Pharmaceutical Research
PharmacologyPharmaceutical Science
2018English

Downregulation of BAG‑1 in T47D Cells Promotes Resistance to Tamoxifen via Activation of the PI3K/Akt/mTOR Signaling Pathway

Oncology Reports
MedicineCancer ResearchOncology
2019English

Retraction: Reversal Effect of ST6GAL 1 on Multidrug Resistance in Human Leukemia by Regulating the PI3K/Akt Pathway and the Expression of P-Gp and MRP1

PLoS ONE
Multidisciplinary
2019English

ITR‑284 Modulates Cell Differentiation in Human Chronic Myelogenous Leukemia K562 Cells

Oncology Reports
MedicineCancer ResearchOncology
2017English

Wogonin Reversed Resistant Human Myelogenous Leukemia Cells via Inhibiting Nrf2 Signaling by Stat3/NF-κB Inactivation

Scientific Reports
Multidisciplinary
2017English

SIRT2 Mediates Multidrug Resistance in Acute Myelogenous Leukemia Cells via ERK1/2 Signaling Pathway

International Journal of Oncology
Cancer ResearchOncology
2015English

Inhibitor of DNA Binding 3 Reverses Cisplatin Resistance in Human Lung Adenocarcinoma Cells by Regulating the PI3K/Akt Pathway

Oncology Letters
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy